Recombinant Bovine Growth Hormone, rbGH, Recombinant Bovine Somatotropin, rBST, human consumption

Document Type



On November 5, 1993, the Food and Drug Administration (FDA) approved Recombinant Bovine Somatotropin (rBST), also JOURNAL OF FOOD LAW & POLICY called Recombinant Bovine Growth Hormone (rbGH), for commercial use to increase milk production in dairy cattle. The FDA determined that milk from cows which have been treated with rBST was safe for human consumption and that there was no significant impact on the environment from the production and use of rBST. In February 1994 the Monsanto Corporation (Monsanto) introduced POSILACO bovine somatotropin, making rBST commercially available to United States dairy farmers.